Laura Alder։ Kicking Off the DCI Small Cell Center at Duke Cancer Institute’s Conference
Laura Alder/LinkedIn

Laura Alder։ Kicking Off the DCI Small Cell Center at Duke Cancer Institute’s Conference

Laura Alder, Thoracic Medical Oncologist at Duke University School of Medicine, shared on LinkedIn:

“Duke Cancer Institute’s conference, Bispecifics, ADCs and Beyond: Challenges and Strategies in Clinical Implementation, was a terrific success!

We were honored to have Dr. Charles Rudin of Memorial Sloan Kettering Cancer Center give the keynote.

He gave an excellent overview of where the field is heading, and we were grateful to have him with us as we kicked off the DCI Small Cell Center.

Thank you to my Duke colleagues for their excellent talks on bispecific administration, tarlatamab symptom management, ADCs in NSCLC, EGFR-mutant disease and approaches to immunotherapy-refractory NSCLC: Cameron Oswalt, Eziafa Oduah, Joel Rivera Concepcion, Sejal D. and Cami Andreini.

Thanks also to Duke Cancer Network for organizing such a well-run meeting.

New therapies are changing the outlook for small cell lung cancer, and we look forward to building on that progress through the new Center!”

Laura Alder

You can also read: Duke Health Launches Small Cell Lung Cancer Center of Excellence.

Duke Health